Bio-Pharmaceuticals API

  • New Product Selection / Portfolio Prioritization based on future market potential in desired geographies
  • Identify APIs for development in synchronization with strength of client
  • Assessment of future manufacturing Line extension in different therapy areas
  • Assessment of company's abilities to tap regulated markets like US, Europe and Japan
  • Evaluation of new process and technology for complex drug molecules
  • Identification of Custom Synthesis opportunities from Innovators late stage pipeline compounds
  • Competitive landscape analysis of targeted therapy areas to assist in new product selection decision
  • Fund Raising and value assessment for Business Expansion

MP Advisors exclusive focus and in-depth understanding of pharma Industry over two decades enables the team to offer advisory services to the pharmaceutical companies engaged in Innovation, manufacturing, formulation of drugs, CROs. Our services also extends to Corporate Investors like Private equities, Venture Capital and Angel Investors. Our proprietary database and acquired domain skills support us in advising Private equity/investors in understanding the risk reward of investing in the pharma sector across the globe-US, Europe, Japan and India.

We integrate the team's knowledge and experience to understand the complex science, dynamic market environment shaped by the regulatory approval process to offer end-to- end solution to our clients which aids them in making timely strategic decisions.

We continuously strive to improve our skill sets and understanding to facilitate our customers to view us as long term strategic partners in their business development.

Our Services

Bio-Pharmaceuticals Formulation
Bio-Pharmaceuticals API
Private Equity, VC & Angel Investors